1. kaejugirl
2. bradengracie
3. kjdegarmo
4. brianpitkin
1.kaejugirl 01/25/2018
Inclisiran's First Pivotal Trial Achieves Target Enrollment Ahead of Schedule
2.bradengracie 01/26/2018
Anyone?? - JPMorgan resumes as an overweight, $45PT
3.kjdegarmo 01/25/2018
great 4 day rally here
4.kaejugirl 01/25/2018
from 24-34.... strong buying here
5.brianpitkin 01/24/2018
big news today! - Chardan Capital reiterates Buy rating, $85 PT
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW